Search

First Neuralink Patient Sees Some Implanted Electrodes Lose Connection to Brain

First Neuralink Patient Sees Some Implanted Electrodes Lose Connection to Brain Neuralink’s first human patient, Noland Arbaugh, experienced some of the implanted electrodes losing connection about 100 days post-surgery. Despite this, Neuralink tweaked its algorithms to boost performance. The N1 implant, with 1,024 electrodes, helped Arbaugh control his laptop and play games. Neuralink aims to […]

Major AlphaFold Upgrade Offers Boost for Drug Discovery

Major AlphaFold Upgrade Offers Boost for Drug Discovery Since the release of AlphaFold2 in 2021, scientists have leveraged its advanced protein structure prediction capabilities for diverse applications, including mapping cellular machinery, drug discovery, and protein universe exploration. Despite its successes, John Jumper, the leader of AlphaFold’s development at Google DeepMind, faced inquiries about expanding the […]

Generative AI Finds Its Footing in Drug Development

Generative AI Makes Strides in Pharmaceutical Innovation Xaira Therapeutics launched with a historic $1 billion investment, aimed at leveraging artificial intelligence for drug discovery and development, particularly emphasizing generative AI. This move reflects a growing interest in harnessing AI’s capabilities within the biopharma industry. Generative AI, capable of producing novel ideas and content, gained traction […]

‘ChatGPT for CRISPR’ Creates New Gene-editing Tools

‘ChatGPT for CRISPR’ Creates New Gene-editing Tools Researchers are leveraging generative artificial intelligence (AI) to design novel CRISPR gene-editing systems, marking a significant advancement in the field. By utilizing a protein language model, a neural network trained on vast protein sequences, scientists have successfully designed CRISPR proteins that demonstrate functionality in laboratory settings. Another team […]

mRNA Drug Offers Hope for Treating a Devastating Childhood Disease

mRNA Drug Offers Hope for Treating a Devastating Childhood Disease A promising mRNA-based drug has shown early success in treating a rare genetic disorder by addressing its core deficiency. Reported in Nature, this breakthrough offers hope for mRNA technology beyond vaccines. Developed by Moderna, the therapy targets propionic acidaemia, restoring metabolic function in affected individuals. […]

Diabetes Drug Slows Development of Parkinson’s Disease

Diabetes Drug Slows Development of Parkinson’s Disease A clinical trial suggests that the diabetes drug lixisenatide, related to the latest generation of obesity drugs, may slow the progression of Parkinson’s disease symptoms. Participants who took lixisenatide for 12 months showed no worsening of their symptoms, offering hope for a condition characterized by progressive loss of […]